36E79725Q0002.docx

DOCX document 26 KB Posted

Attached to
6505--Mycophenolate Mofetil RFI
Solicitation number
36E79725Q0002
Issued by

About this file

This document is a Sources Sought Notice issued by the Department of Veterans Affairs National Acquisition Center for the procurement of Mycophenolate Mofetil capsules and tablets. The notice is conducting market research to establish a national mandatory requirements contract for the VA, Department of Defense, Indian Health Service, Bureau of Prisons, and Federal Health Care Center.

The key details are: the solicitation number is 36E79725Q0002, the response is due by 11/19/2024 at 2:30pm CT, and the procurement will result in a national contract with a base year and up to 4 option years. The agency is seeking offerors that can provide unique 11-digit NDC numbers, have a letter of commitment from the manufacturer if not the manufacturer, have agreements with the Pharmaceutical Prime Vendors, and meet the required packaging sizes and estimated annual usage quantities. The agency is seeking U.S. end-made or designated end-made products, and intends to award at prices lower than FSS/open market based on the committed purchase volume across the agencies.

View the file

On GovTribe

Work with this file

  • Download the original file
  • Contacts named in this file
  • Similar government files
  • Ask GovTribe AI about this file

Text version

Sources Sought Notice Sources Sought Notice

SUBJECT*
Mycophenolate Mofetil RFI

GENERAL INFORMATION

CONTRACTING OFFICE’S ZIP CODE*
60141
SOLICITATION NUMBER*
36E79725Q0002
RESPONSE DATE/TIME/ZONE
11-19-2024 2:30PM CENTRAL TIME, CHICAGO, USA
ARCHIVE
99 DAYS AFTER THE RESPONSE DATE
RECOVERY ACT FUNDS
N

SET-ASIDE

PRODUCT SERVICE CODE*
6505
NAICS CODE*
325412

CONTRACTING OFFICE ADDRESS

POINT OF CONTACT*

Contract Specialist Amber Zavala amber.zavala@va.gov

PLACE OF PERFORMANCE

ADDRESS

POSTAL CODE

COUNTRY

ADDITIONAL INFORMATION

AGENCY’S URL

URL DESCRIPTION

AGENCY CONTACT’S EMAIL ADDRESS
amber.zavala@va.gov
EMAIL DESCRIPTION
amber.zavala@va.gov

DESCRIPTION

MARKET RESEARCH QUESTIONNAIRE

Company Name: _________________________

I am conducting market research for the procurement of Mycophenolate Mofetil capsules and tablets for the Department of Veterans Affairs (VA), Department of Defense (DOD), Indian Health Service (IHS), Bureau of Prisons (BOP), and Federal Health Care Center (FHCC). This procurement will result in a national mandatory requirements contract for the above agencies. Other companies with the same/similar product will be blocked out for ordering; therefore it is our goal to award lower than FSS/Open Market prices on the resultant national contract based on purchases of a committed volume. These products will be awarded in the aggregate for all strengths and sizes for the base year and all option years included in the solicitation. Please provide a response to the following:

1. Is your Company able to meet the following minimum requirements:

a. National Drug Code: Offerors shall provide a separate and distinct eleven-digit National Drug Code (NDC) number unique to the offeror (e.g., 00012-3456-78) for each product proposed. The first five numbers of the eleven-digit NDC number for each product proposed shall identify the offeror. Does your company have a unique NDC (Labeler Code)?_____________

b. If the offeror is not the manufacturer of the offered items, the offeror shall submit a letter of commitment from the manufacturer to the offeror which will assure the offeror a source of supply sufficient to satisfy the Government's requirements for the contract period. Name of Manufacturer:_________________

Is the Manufacturer a Large or Small business (using the SBA size standards for NAICS code 325412? ____________________

Would you be able to provide a letter of commitment from the manufacturer of the offered drug?_____________

c. Pharmaceutical Prime Vendor: All Ordering Activities under the Department of Veterans Affairs and Department of Defense acquire their pharmaceutical requirements through their Pharmaceutical Prime Vendor Program (PPV). The contractor shall ensure that chargeback agreements with the PPVs have been executed with sufficient time to permit the PPVs to begin timely distribution of Government orders, if an award is made. Does your company currently have a business-to-business agreement with the PPVs?_________

d. Under NAICS code 325412, is your company size (check one):

Large Business ______ Small Business ______

e. If a small business, does your company manufacture (measure, weigh, mix, and compound) at least 50% of the product offered?_________

f. Is the offered end product U.S end-made or designated end made product?_________

g. Can your company meet the following product, bottle size and usage:

ITEM
DESCRIPTION
PACKAGE SIZE (Capsules/Tablets per Bottle)
TOTAL ESTIMATED ANNUAL USAGE (Bottles)
1
MYCOPHENOLATE MOFETIL 250MG CAP
100
18,706
2
MYCOPHENOLATE MOFETIL 250MG CAP
500
17,378
3
MYCOPHENOLATE MOFETIL 500MG TAB
100
7,307
4
MYCOPHENOLATE MOFETIL 500MG TAB
500
18,281

2 . Is your Company interested in submitting a response to a solicitation?________

3. As this is a national standardized contract, our preference is for a base plus four option years to provide our customers continuity and consistency of product by allowing long term committed purchases of your product. If interested, please indicate Base year and how many Option periods, not to exceed 4._________________

4. If an award were to be made based on the above requirements, would your company be able to begin supplying the product in the estimated quantities within 60 days of the contract award date?

5. If your company is not interested in participating, please respond with the reason why. This aids our market research for future procurements.

Please provide your responses as soon as possible. Please contact Amber Zavala for any questions. Amber.Zavala@va.gov.

*= Required Field
Sources Sought Notice

Sources Sought Notice

File details come from the government source that posted it. Updated .